75
Views
0
CrossRef citations to date
0
Altmetric
Letters

Utilization and cost of bexarotene in the Medicare population: 2013 to 2017

ORCID Icon, , &
Pages 2400-2401 | Received 23 Jul 2021, Accepted 08 Aug 2021, Published online: 27 Aug 2021
 

Ethical approval

This study did not involve human subjects and utilized publicly available data. Yale University institutional review board approval was not required.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.